Clinical Trials Browser

Infusions, Intravenous × Tumor-Agnostic × Clear all

NCT01023958 2017-11-22

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Phase 2 Completed

50 enrolled 29 charts

Neoplasms